GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Locus Cell Co Ltd (ROCO:06891) » Definitions » Gross-Profit-to-Asset %

Locus Cell Co (ROCO:06891) Gross-Profit-to-Asset % : 0.01% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Locus Cell Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Locus Cell Co's annualized Gross Profit for the quarter that ended in Jun. 2024 was NT$0.19 Mil. Locus Cell Co's average Total Assets over the quarter that ended in Jun. 2024 was NT$1,914.33 Mil. Therefore, Locus Cell Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 was 0.01%.


Locus Cell Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Locus Cell Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Locus Cell Co Gross-Profit-to-Asset % Chart

Locus Cell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
- - 0.02 0.01

Locus Cell Co Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.04 0.04 0.01

Competitive Comparison of Locus Cell Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Locus Cell Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Locus Cell Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Locus Cell Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Locus Cell Co's Gross-Profit-to-Asset % falls into.



Locus Cell Co Gross-Profit-to-Asset % Calculation

Locus Cell Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=0.171/( (2001.873+1915.337)/ 2 )
=0.171/1958.605
=0.01 %

Locus Cell Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2024 )/( (Total Assets (Q: Mar. 2024 )+Total Assets (Q: Jun. 2024 ))/ count )
=0.192/( (1902.246+1926.411)/ 2 )
=0.192/1914.3285
=0.01 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Jun. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Locus Cell Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Locus Cell Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Locus Cell Co Business Description

Traded in Other Exchanges
N/A
Address
Xintai 5th Road, 19th FLoor.-12, No.97, Section 1, Xizhi District, New Taipei, TWN
Locus Cell Co Ltd focuses on contract development and manufacturing services for cell therapy-related products.

Locus Cell Co Headlines

No Headlines